These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31639737)

  • 1. Embracing Procalcitonin for Antimicrobial Stewardship.
    Chambliss AB
    J Appl Lab Med; 2019 Jan; 3(4):712-715. PubMed ID: 31639737
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin and Its Limitations: Why a Biomarker's Best Isn't Good Enough.
    Farooq A; Colón-Franco JM
    J Appl Lab Med; 2019 Jan; 3(4):716-719. PubMed ID: 31639738
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of procalcitonin as a tool for antibiotic stewardship.
    Murri R; Taddei E; Cauda R; Fantoni M
    Future Microbiol; 2019 Jan; 14():77-79. PubMed ID: 30644309
    [No Abstract]   [Full Text] [Related]  

  • 4. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges.
    Fung AWS; Beriault D; Diamandis EP; Burnham CD; Dorman T; Downing M; Hayden J; Langford BJ
    Clin Chem; 2017 Sep; 63(9):1436-1441. PubMed ID: 28634222
    [No Abstract]   [Full Text] [Related]  

  • 7. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can procalcitonin guide decisions about antibiotic management?
    Fakheri RJ
    Cleve Clin J Med; 2019 May; 86(5):307-311. PubMed ID: 31066663
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Müller A
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S6-S7. PubMed ID: 30453362
    [No Abstract]   [Full Text] [Related]  

  • 13. Hospital physicians' experiences with procalcitonin - implications for antimicrobial stewardship; a qualitative study.
    Christensen I; Haug JB; Berild D; Bjørnholt JV; Jelsness-Jørgensen LP
    BMC Infect Dis; 2020 Jul; 20(1):515. PubMed ID: 32677903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I].
    Shapoval SD; Savon IL; Martyniuk VB; Vasylevska LA; Yakunych AM; Maksimova OO; Sofilkanych MM
    Klin Khir; 2015 Jun; (6):62-6. PubMed ID: 26521472
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of biomarkers in antimicrobial stewardship: physicians' perspectives.
    Seok H; Park DW
    Korean J Intern Med; 2024 May; 39(3):413-429. PubMed ID: 38715231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized antibiotic therapy in the treatment of severe infections.
    Annoni F; Grimaldi D; Taccone FS
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):27-35. PubMed ID: 31755789
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.
    Williams EJ; Mair L; de Silva TI; Green DJ; House P; Cawthron K; Gillies C; Wigfull J; Parsons H; Partridge DG
    J Hosp Infect; 2021 Apr; 110():103-107. PubMed ID: 33484783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.
    Fantoni M; Taddei E; Cauda R; Antonelli Incalzi R; Capone A; Cortese F; Sanguinetti M; Spandonaro F; Urbani A; Murri R
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2978-2985. PubMed ID: 31002168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin-guided antibiotic stewardship from newborns to centennials.
    Schuetz P; Mueller B
    Lancet; 2017 Aug; 390(10097):826-829. PubMed ID: 28711319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.